Startup India Government of India
Wrightpharm Mediscinces Private Limited
Wrightpharm Mediscinces Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹30.02 Lakh
▲ 123% YoY
Net profit · FY 2023
₹97,686
Net margin 3.3%
EBITDA · FY 2023
₹1.34 Lakh
EBITDA margin 4.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Wrightpharm Mediscinces Private Limited
Data last updated:
Wrightpharm Mediscinces Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33309MH2018PTC305378. Its GSTIN is 27AACCW1529P1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tejaswini Abasaheb Bhosale and Vijay Rajaram More.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 3 A #704 A Wing D3 Satelite Garden Phase 2 Gokuldham Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.02 Lakh, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹97,686 (net margin 3.3%) and EBITDA of ₹1.34 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
Wrightpharm Mediscinces Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0060194).
Company details
CIN U33309MH2018PTC305378
Registration Number 305378
Incorporation Date 21 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0060194
Recognitions & Rankings of Wrightpharm Mediscinces
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0060194
Contact details
Wrightpharm Mediscinces Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 3 A #704 A Wing D3 Satelite Garden Phase 2 Gokuldham Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Wrightpharm Mediscinces Private Limited, buy the company report.
Comprehensive company report
Wrightpharm Mediscinces Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wrightpharm Mediscinces is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wrightpharm Mediscinces Private Limited, buy the company report.
Financials of Wrightpharm Mediscinces Private Limited
FY 2024 filings availableWrightpharm Mediscinces Private Limited reported revenue of ₹30.02 Lakh (up 123% YoY) for FY 2023.
Revenue · FY 2023
₹30.02 Lakh ▲ 123%
Net profit · FY 2023
₹97,686 margin 3.3%
EBITDA · FY 2023
₹1.34 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 123%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▼ 12%
5 years · compounded
▲ 33%
Revenue has grown at a compounded annual rate (CAGR) of 52% over three years, including 123% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97,686 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wrightpharm Mediscinces Private Limited, buy the company report.
Board of directors of Wrightpharm Mediscinces Private Limited
Wrightpharm Mediscinces has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tejaswini Abasaheb Bhosale | Director | 21 Feb 2018 | 8 Years 8 Months | Current |
| Vijay Rajaram More | Director | 21 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Wrightpharm Mediscinces Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rubra Pharmaceuticals Limited | ₹30.15 Lakh (FY 2025) | -8.0% | Telangana, India | |||
| Radix Life Sciences Private Limited | ₹30.06 Lakh (FY 2025) | 6.0% | Lucknow, Uttar Pradesh, India | |||
| Wrightpharm Mediscinces Private Limitedthis company | ₹30.02 Lakh (FY 2023) | ₹97,686 | 3.3% | 123.0% | Mumbai, Maharashtra, India | |
| Chadha Tradelinks Private Limited | ₹30.02 Lakh (FY 2025) | 23.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Wrightpharm Mediscinces Private Limited, buy the company report.
Auditor
Wrightpharm Mediscinces Private Limited is audited by R V JHA & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R V JHA & COMPANY | FY 2022 | 146173W |
Shareholding
The shareholding of Wrightpharm Mediscinces Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Wrightpharm Mediscinces Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wrightpharm Mediscinces Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wrightpharm Mediscinces Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wrightpharm Mediscinces has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCW1529P1ZV | Maharashtra | Active | 02 Apr 2018 |
To see the full GST registrations and return filing status of Wrightpharm Mediscinces Private Limited, buy the company report.
Recent activity
Wrightpharm Mediscinces Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Tejaswini Abasaheb Bhosale was appointed as Director on 21 Feb 2018.
AGM
Wrightpharm Mediscinces Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Wrightpharm Mediscinces Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Appointed
Tejaswini Abasaheb Bhosale was appointed as Director.
Appointed
Vijay Rajaram More was appointed as Director.
Incorporation
21 Feb 2018
Wrightpharm Mediscinces Private Limited was registered on 21 Feb 2018 with Roc Mumbai I & aged 8 years 8 months as per MCA records.
Frequently asked questions
Wrightpharm Mediscinces is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 February 2018 (8+ years old) and is registered under CIN U33309MH2018PTC305378.
Wrightpharm Mediscinces has 2 current directors:
- Tejaswini Abasaheb Bhosale - Director
- Vijay Rajaram More - Director
The latest financial statements of Wrightpharm Mediscinces on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Wrightpharm Mediscinces is 27AACCW1529P1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Wrightpharm Mediscinces is U33309MH2018PTC305378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wrightpharm Mediscinces was incorporated on 21 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Wrightpharm Mediscinces by revenue are Rubra Pharmaceuticals Limited, Radix Life Sciences Private Limited, Chadha Tradelinks Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Tejaswini Abasaheb Bhosale was appointed as Director on 21 Feb 2018. Vijay Rajaram More was appointed as Director on 21 Feb 2018.
Yes, Wrightpharm Mediscinces is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Wrightpharm Mediscinces is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0060194).
The registered office of Wrightpharm Mediscinces is at D – 3 A #704 A Wing D3 Satelite Garden Phase 2 Gokuldham Goregaon East, Mumbai, Maharashtra, India – 400063.